Immuno Oncology

Immuno oncology is the fake incitement of the invulnerable framework to treat malignant growth, enhancing the resistant framework's normal capacity to battle the illness.It is an utilization of the crucial research of disease immunology and a developing subspeciality of oncology. It abuses the way that malignant growth cells regularly have tumor antigens, atoms on their surface that can be identified by the immunizer proteins of the insusceptible framework, official to them. The tumor antigens are often proteins or other macromolecules.Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. In 2018, James P. Allison and Tasuku Honjo got the Nobel Prize in Physiology or Medicine for their revelation of malignancy treatment by hindrance of negative invulnerable guideline.

  • Monoclonal antibodies and tumor-agnostic therapies

Related Conference of Immuno Oncology

March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France

Immuno Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in